On November 16, Professor and Director Ronald Evans shared clinical trial updates on pancreatic cancer, a devastating disease with only 8 percent of patients surviving more than five years. Evans shared research breakthroughs, including immunotherapy and a vitamin D derivative.
Power of science: conquering pancreatic cancer
![](https://inside.salk.edu/wp-content/uploads/2021/05/2021spring-events-pos-pancreatic-cancer.jpg)